EWTX today
$45.82-$1.75 (-3.68%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourSymmetric Triangle
1 hourBearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $38.38
Key levels
Resistance$48.51
Support$44.92
Support$41.63
Latest news & SEC filings
DealEdgewise Therapeutics said to weigh a possible sale of itself
NewsEdgewise Therapeutics shares rise amid unconfirmed takeover rumor
ProductEdgewise Therapeutics gets positive feedback from FDA on EDG-7500
AnalystWedbush keeps Outperform rating on Edgewise Therapeutics, cuts target to $51
All EWTX news →About Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company that develops small molecule precision medicines for severe muscle diseases. Its lead product candidate, sevasemten, is an oral fast myofiber myosin inhibitor being studied for Duchenne and Becker muscular dystrophies. The company also develops cardiac sarcomere modulators, including EDG-7500 for hypertrophic cardiomyopathy and EDG-15400 for a form of diastolic heart failure, and has a preclinical cardiometabolic program. It operates in the United States and has kept worldwide rights to develop and sell its programs.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Edgewise Therapeutics, Inc. (EWTX)
What Is the Price Target for EWTX?
SEPT Low Target
$36.00
SEPT Mid Target
$51.00
SEPT High Target
$59.00
Analyst Consensus
$51.00
Is EWTX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EWTX.
Start Free Trial →Is EWTX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$46.80
29
Moat Score
NONE
2/9
Piotroski Score
93.3
Altman Z-Score
What Is Smart Money Doing with EWTX?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Nofi Michael | officer | Buy | 10,937 | - | Nov 10, 2026 |
| Nofi Michael | officer | Sale | 4,442 | $202K | Nov 10, 2026 |
| Fox Jonathan C | director | Buy | 308 | - | Oct 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EWTX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-12.41%
FCF Growth YoY
-30.6%
Revenue Trend
UNKNOWN
Dark Pool Trades for EWTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EWTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:09 | $47.57 | 1,187 | $$56K | SELL |
| 21:00:09 | $47.57 | 3,623 | $$172K | SELL |
| 21:00:09 | $47.57 | 1,596 | $$76K | SELL |
| 20:57:07 | $47.48 | 1,140 | $$54K | BUY |
| 20:36:28 | $47.20 | 1,800 | $$85K | SELL |
5 dark pool trades shown · $$444K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for EWTX
PREVIEWSEPT Investing provides real-time options flow tracking for EWTX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $38 | Jan 15 | 65 | $$1652 | 7 | SWEEP |
| PUT | $44 | Jan 15 | 65 | $$2751 | 7 | SWEEP |
| CALL | $49 | Jan 15 | 65 | $$2814 | 7 | SWEEP |
| PUT | $38 | Jan 15 | 65 | $$2178 | 9 | SWEEP |
| PUT | $44 | Jan 15 | 65 | $$3546 | 9 | SWEEP |
5 options trades shown · 20% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About EWTX
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for EWTX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $TXO — SIMPSON BOB R | Sale $1.2M $EWTX — Nofi Michael | Sale $EWTX — Nofi Michael | Sale $202K $OESX — BRODIN J PER | Sale $26K $BOLD — TANG KEVIN | Sale $1K
Join 3,500+ traders discussing EWTX in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Edgewise Therapeutics, Inc. (EWTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EWTX — frequently asked questions
What is EWTX stock price today?
Edgewise Therapeutics, Inc. (EWTX) is at $45.82, down 3.68% (-$1.75) at the Nov 12, 2026 close.
Why is EWTX stock moving today?
Latest EWTX news — Nov 7, 2026: Edgewise Therapeutics said to weigh a possible sale of itself · Nov 6, 2026: Edgewise Therapeutics shares rise amid unconfirmed takeover rumor
What is the EWTX price target?
The average analyst price target for EWTX is $51.00, ranging from $36 to $59, based on 7 analysts. Latest: Wedbush maintains on Nov 5, 2026.
What do analysts rate EWTX?
Analyst ratings for EWTX: 0 Buy, 12 Hold, 0 Sell — consensus Hold.
Did EWTX beat earnings?
EWTX last reported on Nov 5, 2026: EPS $0.84 vs -$0.52 expected — a beat of 261.1%.
What is EWTX's P/E ratio?
EWTX trades at a P/E of 5.8 vs a Healthcare average of 17.7.
Does EWTX pay a dividend?
EWTX does not currently pay a dividend.
What are EWTX support and resistance levels?
Support: $44.92, $41.63, $36.70. Resistance: $48.51.
What are insiders doing with EWTX?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on EWTX?
Nov 7, 2026: Edgewise Therapeutics said to weigh a possible sale of itself · Nov 6, 2026: Edgewise Therapeutics shares rise amid unconfirmed takeover rumor · Nov 5, 2026: Edgewise Therapeutics gets positive feedback from FDA on EDG-7500